ZEISS Medical Technology announced today that the CLARUS® 700 from ZEISS has received National Medical Products ...

Investor capital is pouring into AI-driven healthcare, with Pittsburgh-based Abridge AI Inc. pulling in $300 million at a ...

Paradigm Medical Communications Logo Paradigm Medical Communications, LLC and the American Academy of Ophthalmology Announce the Continuati ...

Specialist eye hospital group Optegra, which operates a clinic in Brighton has been officially recognised as one of the UK’s ...

Specialist eye hospital group Optegra, which operates a hospital in Birmingham and a clinic in Uttoxeter, has been officially ...

Frontage Laboratories, Inc. officially unveiled its newest Contract Research, Development and Manufacturing Organization (CRDMO) facility during a grand open house event held on May 22, 2025, at its ...

MILAN (Reuters) -Essilorluxottica has entered an agreement to buy Optegra ophthalmic clinics from MidEuropa, as the ...

Ryan Kingerski died after suffering debilitating vision problems from surgery to correct his vision, his family says. What to ...

Key trends include advanced multicolor laser adoption and increased outpatient treatments. Challenges include reimbursement issues and competition from alternative therapies. Leading players like ...

The pharmaceutical testing lab BRS Analytical Service recalled products used to relieve dry and irritated eyes after "deviations" were found in adhering to FDA safety regulations.

Detailed price information for Sight Sciences Inc (SGHT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.